Tempus AI (TEM) Gains from Sales and Divestitures (2024 - 2025)
Tempus AI (TEM) reported Gains from Sales and Divestitures of $2.8 million for Q4 2025, down 76.65% year-over-year from $12.1 million in Q4 2024, and down 76.65% on a QoQ basis from $12.1 million in Q4 2024.
Tempus AI (TEM) has 2 years of Gains from Sales and Divestitures data on file, last reported at $2.8 million in Q4 2025.
- Quarterly Gains from Sales and Divestitures fell 76.65% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (down 76.65% YoY) and the FY2025 annual result came in at $2.8 million, down 76.65% from the prior year.
- Gains from Sales and Divestitures retreated to $2.8 million in Q4 2025 per TEM's latest filing, from $12.1 million in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $12.1 million in Q4 2024 and bottomed at $2.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Tempus AI | 9.58 Mn | -629.49 Mn | 323.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.84 Mn |
| Dec 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 12.14 Mn |
| Dec 31, 2024 | 12.14 Mn |
| Sep 30, 2024 | 5.57 Mn |
| Sep 30, 2024 | 5.57 Mn |